Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

N-Acetylcysteine for Smoking Cessation in Tobacco and Cannabis Co-Use: A Randomized Controlled Trial

NCT04627922 is registered in ClinicalTrials.gov with Ellen Herbst as lead sponsor.

NCT NCT04627922
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04627922 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
N-Acetylcysteine for Smoking Cessation in Tobacco and Cannabis Co-Use: A Randomized Controlled Trial
Lead sponsor
Ellen Herbst
Phase
Phase 4
Overall status
Completed
Start date
August 25, 2021
Completion date
June 30, 2025
Enrollment
41 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cannabis use, drug use disorder, tobacco use disorder